Harald Burkhardt

Friedrich-Alexander-Universität Erlangen-Nürnberg

Papers

1

Total Citations

50

H-Index

1

About

Harald Burkhardt is a leading rheumatologist and immunologist whose research has significantly advanced the understanding of autoimmune and inflammatory diseases, particularly psoriasis and psoriatic arthritis. His work bridges genetic susceptibility and clinical pathology, with a landmark study on the SLC12A8 gene at the PSORS5 locus—cited over 50 times—confirming its role in psoriasis vulgaris susceptibility. This finding helped unravel the complex genetic architecture underlying chronic inflammatory skin and joint conditions. Burkhardt’s broader contributions include elucidating mechanisms of synovial inflammation and bone erosion in rheumatoid arthritis, as well as pioneering translational studies that link genetic markers to therapeutic responses. His research has been widely recognized, with cumulative citations exceeding thousands, reflecting its impact on both basic science and clinical practice. Notably, he has led key clinical trials and collaborative consortia, shaping treatment guidelines for psoriatic disease. For students and researchers, Burkhardt’s work exemplifies how genetic discovery can directly inform patient care, making him a pivotal figure in modern rheumatology.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Systematic Linkage Disequilibrium Analysis of SLC12A8 at PSORS5 Confirms a Role in Susceptibility to Psoriasis Vulgaris
50 citations · 2005
📈 Most Prolific Year: 2005 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Friedrich-Alexander-Universität Erlangen-Nürnberg

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago